In fiscal year 2025 Pfizer reported $62.6B in revenue against AbbVie's $61.2B, 1.02× as much.
| Measure | ABBV | PFE | Gap |
|---|---|---|---|
| Revenue | $61.2B | $62.6B | ×1.02 |
| Cost of revenue | $18.2B | $16.1B | ×1.13 |
| Operating income | $15.1B | $7.5B | ×2.00 |
| Net income | $4.2B | $7.8B | ×1.84 |
| EPS (diluted) | 2.36 | 1.36 | ×1.74 |
| Total assets | $134B | $208B | ×1.55 |
| Total liabilities | $137B | $121B | ×1.13 |
| Shareholders' equity | −$3.3B | $86.5B | — |
| Cash | $5.2B | $1.1B | ×4.58 |
| Long-term debt | $64.5B | $61.6B | ×1.05 |
| Net margin | 6.9% | 12.4% | ×1.80 |
| Operating margin | 24.6% | 12.0% | ×2.05 |
| Operating cash flow | $19.0B | $11.7B | ×1.63 |
| Capital expenditure | $1.2B | $2.6B | ×2.17 |
| Free cash flow | $17.8B | $9.1B | ×1.96 |
| R&D expense | $9.1B | $10.4B | ×1.15 |
| Income tax expense | $2.4B | −$266M | — |
| Share buybacks | $980M | $0 | — |
The larger of the two figures is in bold. Larger is not automatically better: on debt, cost and tax a bigger number is simply a bigger number. This site reports the figures and leaves the judgement to you.
Revenue, year by year
AbbVie · 2016–2025
Pfizer · 2016–2025
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=AbbVie vs Pfizer |url=https://companiesranked.com/en/compare/abbvie-vs-pfizer |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). AbbVie vs Pfizer. CompaniesRanked. https://companiesranked.com/en/compare/abbvie-vs-pfizerBibTeX
@misc{companiesranked-en-compare-abbvie-vs-pfizer-2026,
author = {{CompaniesRanked}},
title = {{AbbVie vs Pfizer}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/compare/abbvie-vs-pfizer}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.